In the meeting of Board of Directors of the Company held on 12.05.2025 i.e. today, the Board has inter-alia considered and approved the Audited Financial Results (both Standalone & Consolidated) ....
SICAGEN · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
The Board of Sicagen India Ltd, at its meeting on May 12, 2025, approved the audited financial results for Q4 and FY ending March 31, 2025. On a consolidated basis, revenue from operations rose to Rs. 89,188 lakhs from Rs. 79,545 lakhs (~12% YoY), while net profit grew to Rs. 1,711 lakhs from Rs. 1,052 lakhs (~63% YoY). Standalone revenue stood at Rs. 53,915 lakhs with net profit of Rs. 1,453 lakhs (vs Rs. 885 lakhs last year). The Board recommended a 10% equity dividend (Re. 1 per share) for FY25, subject to shareholder approval. The auditor (SRSV & Associates) issued an unmodified opinion on both standalone and consolidated results.
Strong profit growth and a healthy dividend declaration signal solid operational performance, likely to be viewed positively by shareholders. Re-appointment of existing auditors maintains continuity, while the new 5-year secretarial auditor appointment is a routine governance measure.